Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™) (FR TFNA)

A Focused Registry on the Titanium Trochanter Fixation Nail Advanced (TFNAdvanced™) - TFNA System in Patients With Proximal Inter-, Per- or Subtrochanteric Fractures

The aim of this project is the prospective data collection of a new device used for trochanteric fractures of the femur. It should be answered how the newly developed implant called Trochanteric Fixation Nailing with anti-rotation feature (TFNA) is performing clinically and radiological in terms of intra- and postoperative complications.

Study Overview

Detailed Description

In comparison to previous implants, the TFNA has been improved substantially. Therefore the purpose of this focused registry is to investigate how the newly developed implant called Trochanteric Fixation Nailing with anti-rotation feature (TFNA) is performing clinically and radiologically in terms of surgical technique, intra- and postoperative complications and short term outcome.

All investigated procedures are part of the standard of care treatment. Only the parker mobility score is study-specific. All patients included are followed up from the time point of enrollment until three months after surgery.

Study Type

Observational

Enrollment (Actual)

35

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Innsbruck, Austria, 6020
        • Medical University Innsbruck
      • Liestal, Switzerland, 4410
        • Kantonsspital Baselland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with per- or intertrochanteric fractures of the femur, fracture of the trochanteric area with diaphyseal extension or combined fractures of the trochanteric area and the femoral shaft.

Description

Inclusion Criteria:

  • Age 18 years and older
  • Pertrochanteric femoral fracture (31-A1 and 31-A2), intertrochanteric fracture (31-A3), fracture of the trochanteric area (31-A1/A2/A3) with diaphyseal extension or combined fracture of the trochanteric area and the femoral shaft (32-A/B/C) treated with the TFNA system according to the technique guide
  • Ability to understand the content of the patient information / informed consent form
  • Willingness and ability to participate in the registry according to the registry plan (RP)
  • Signed and dated IRB/EC-approved written informed consent or assent from a family member

Exclusion Criteria:

  • Additional acute fracture
  • Any not medically managed severe systemic disease
  • Recent history of substance abuse (i.e., recreational drugs, alcohol) that would preclude reliable assessment
  • Pregnancy or women planning to conceive within the registry period
  • Prisoner
  • Participation in any other medical device or medicinal product registry within the previous month that could influence the results of the present registry
  • Intraoperative decision to use implants other than the devices under investigation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of mechanical and surgical complications defined as the number of
Time Frame: up to 3 months
  • cut out and cut through
  • secondary displacement of parts of the implant
  • breakage of the implant
  • iatrogenic fractures
  • surgical revisions
  • acute deep infection
up to 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
OR time
Time Frame: Intraoperative
(in min)
Intraoperative
Fracture classification Classification
Time Frame: Baseline
according to AO/OTA Fracture and Dislocation
Baseline
Parker Mobility Score
Time Frame: up to 3 months
Evaluation of the mobility
up to 3 months
Quality of reduction and implant placement
Time Frame: up to 3 months
Based on radiographic analysis with focus on the position of the nail tip relative to the femoral canal and the migration of the head neck element
up to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael Blauth, Professor, Medical University Innsbruck, Department of Trauma Surgery

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Actual)

June 1, 2016

Study Completion (Actual)

November 1, 2017

Study Registration Dates

First Submitted

November 22, 2014

First Submitted That Met QC Criteria

December 1, 2014

First Posted (Estimate)

December 2, 2014

Study Record Updates

Last Update Posted (Actual)

August 12, 2020

Last Update Submitted That Met QC Criteria

August 11, 2020

Last Verified

August 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pertrochanteric Fractures of Femur

Clinical Trials on TFNA

3
Subscribe